APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CDC73 | Cell division cycle 73 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERCC4 | Excision repair cross-complementing rodent repair deficiency, complementation group 4 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ERCC5 | Excision repair cross-complementing rodent repair deficiency, complementation group 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
FANCE | Fanconi anemia, complementation group E | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
FANCG | Fanconi anemia, complementation group G | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FH | Fumarate hydratase | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
FLCN | Folliculin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MLH1 | MutL homolog 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MSH2 | MutS homolog 2 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MSH6 | MutS homolog 6 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
NBN | Nibrin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NF2 | Neurofibromin 2 (merlin) | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
PALB2 | Partner and localizer of BRCA2 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
PRKAR1A | Protein kinase, cAMP-dependent, regulatory, type I, alpha | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
PTCH1 | Patched 1 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
RB1 | Retinoblastoma 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
RECQL4 | RecQ protein-like 4 | Cancer-related genes
| | | | | Mixed |
RP11-286N22.8 | Uncharacterized protein | Cancer-related genes
| | | | | Expressed in all |
SBDS | Shwachman-Bodian-Diamond syndrome | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SDHAF2 | Succinate dehydrogenase complex assembly factor 2 | Cancer-related genes Disease related genes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
SDHB | Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
STK11 | Serine/threonine kinase 11 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
SUFU | Suppressor of fused homolog (Drosophila) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
TP53 | Tumor protein p53 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transcription factors Transporters
| | | | | Expressed in all |
TSC1 | Tuberous sclerosis 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TSHR | Thyroid stimulating hormone receptor | Cancer-related genes Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
XPA | Xeroderma pigmentosum, complementation group A | Cancer-related genes Disease related genes
| | | | | Expressed in all |
XPC | Xeroderma pigmentosum, complementation group C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |